Estrella Immunopharma (ESLA)

• Market cap: $47.4M
• 1 day: -8.26%
• 5 days: -11.9%
• 1 month: -35.84%
• 3 months: -13.28%
• 6 months: -40.32%
• Year to date: -20.14%
• 1 year: 18.07%
• 5 years: -88.62%
• 10 years: -88.62%
• Sector: Healthcare
• Industry: Biotechnology

About: Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors.